Full Breakdown
Ancient Bacteria from Romanian Ice Cave Offers Insights into Antibiotic Resistance
2/17/2026, 7:48:00 PM
Discovery of Psychrobacter SC65A.3
Researchers in Romania have isolated a bacterial strain named Psychrobacter SC65A.3 from a 5,000-year-old layer of ice in the Scarisoara Ice Cave. This strain, part of a genus known for its cold-adapted bacteria, has shown resistance to multiple modern antibiotics and carries over 100 resistance-related genes. The findings were published in the journal *Frontiers in Microbiology*. Dr. Cristina Purcarea, a senior scientist at the Institute of Biology Bucharest of the Romanian Academy, emphasized the significance of this discovery, noting that the strain not only resists antibiotics but also inhibits the growth of several antibiotic-resistant "superbugs."
Methodology and Findings
To study the strain, the research team drilled an 82-foot (25-meter) ice core from the Great Hall of the cave, representing a timeline of 13,000 years. The ice samples were carefully handled to prevent contamination. In the laboratory, the researchers sequenced the genomes of various bacterial strains and tested SC65A.3 against 28 antibiotics from 10 different classes. The antibiotics tested included rifampicin, vancomycin, and ciprofloxacin, which are commonly used to treat serious bacterial infections such as tuberculosis and urinary tract infections (UTIs). Notably, SC65A.3 is the first Psychrobacter strain identified with resistance to antibiotics like trimethoprim, clindamycin, and metronidazole.
Implications for Antibiotic Resistance
The resistance profile of Psychrobacter SC65A.3 suggests that bacteria capable of surviving in extreme cold may serve as reservoirs for resistance genes, which could pose a risk if these genes spread to modern bacterial strains. Dr. Purcarea warned that melting ice could release these microbes, potentially exacerbating the global challenge of antibiotic resistance. However, the strain also presents opportunities; it produces unique enzymes and antimicrobial compounds that could inspire the development of new antibiotics and biotechnological innovations.
Criticism and Concerns
While the discovery holds promise, it also raises concerns about the potential risks associated with studying ancient bacteria. The unknown functions of nearly 600 genes found in the SC65A.3 genome highlight the need for careful handling and safety measures in laboratory settings to mitigate the risk of uncontrolled spread.
Conclusion
The study of Psychrobacter SC65A.3 underscores the important role that ancient microorganisms play in understanding the evolution of antibiotic resistance. As antibiotic resistance continues to be a pressing public health issue, exploring these ancient genomes may provide critical insights for future medical advancements. Dr. Purcarea concluded, “These ancient bacteria are essential for science and medicine,” emphasizing the need for responsible research practices.
